Calculate Your Salary Ranking
Home > Dor Biopharma Salary

Dor Biopharma Salary
  • 17
  • 10
  • 48

Dor Biopharma average salary is $119,720, median salary is $100,000 with a salary range from $60,600 to $275,000.
Dor Biopharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. Dor Biopharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 4 Dor Biopharma Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Vice President Of Clinical Operations 100,000-100,000 Miami Beach, FL, 33109 2010 Dor Biopharma Vice President Of Clinical Operations Salaries (2)
Dor Biopharma Miami Beach, FL Salaries
General 275,000-275,000 Lake Forest, IL, 60045 2010 Dor Biopharma General Salaries (1)
Dor Biopharma Lake Forest, IL Salaries
Research Scientist 63,000-63,000 Lake Forest, IL, 60045 2010 Dor Biopharma Research Scientist Salaries (1)
Dor Biopharma Lake Forest, IL Salaries
Senior Research Scientist I 60,600-60,600 Alachua, FL, 32615 2010 Dor Biopharma Senior Research Scientist I Salaries (1)
Dor Biopharma Alachua, FL Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Dor Biopharma Salaries (October 28, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Dor Biopharma salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Dor Biopharma Information
  • DOR BioPharma , Inc.
  • Industry: Other
  • City: Ewing, NJ
  • DOR Biopharma, Inc. (DOR) is a research and development biopharmaceutical company focused on the development of oral therapeutic products intended for areas of unmet medical need, as well as therapeutic and vaccine products. The Company operates in two business segments: BioDefense and BioTherapeutics. Its BioDefense business segment consists of converting biodefense vaccine programs from early stage development to advanced development and manufacturing. DOR's BioTherapeutic business segment consists of development of oral beclomethasone dipropionate (orBec) and other BioTherapeutics products, such as Oraprine, lipid polymer micelle (LPM), LPE and PLP Systems for Delivery of Water-Insoluble Drugs.